Home of skin cancer education

Directed by dermatologists & dermatopathologists


Sunset from the ACCO Centre, Melbourne CBD

The Australasian College of Cutaneous Oncology provides practical and theory-based training and education to improve and certify competency in the management of skin cancer. Our policy is that no pharmaceutical company shall be permitted to sponsor or endorse any event, function or workshop in any manner.  This creates a truly unique and unbiased learning environment.

July 2020 - Editorial on Sentinel biopsy by Sam Zagarella

COVID-19 - ACCO suspends programs for 2020

  • All ACCO programs including workshops scheduled for April and July 2020 have been postponed until 2021. 
  • The Essentials workshop will now take place on Saturday 24 and Sunday 25 April 2021 
  • The Dermoscopy workshop will now take place on Sunday 25 and Monday 26 April 2021
  • The Combined Essentials and Dermoscopy workshops can be completed back to back on April 24 / 25 / 26 2021
  • The Flap and Graft workshop will now take place over the five days: June 11-15th 2021 (including Queens Birthday weekend) 
  • The Face and Ear Reconstruction workshop will now take place 30 October to 1 November 2021
  • The 1-Day Dermatopathology workshop will now take place Tuesday 2 November 2021. 

ACCO will provide full refunds to all registrants who were hoping to attend our workshops in 2020. 

You may also choose to defer your course fee to 2021. 

For more information, please contact us at admin@acco.edu.au

COVID - 19 Do I need to alter my skin cancer management?

As of May 20, 2020, ACCO recommends: 

  1. Limit skin cancer checks to patients with a past history of skin cancer or marked actinic damage.
  2. Using gloves and hand washing is essential before and after each skin check.
  3. Polarised dermoscopy allows no contact between patient and instrument. This can be an advantage in these situations.
  4. Delay procedures to manage minor lesions and indolent skin cancers including SCC in situ and superficial BCCs.
  5. Surgery for wide local excision of melanoma, invasive SCC, or other BCCs should not be delayed on this basis alone.
  6. Consider reception triaging patients need for skin checks. Low risk patients can be asked to book at a later date.
  7. Any patient unwell with upper respiratory symptoms and / or fever should have a skin check deferred and should be advised to contact their local GP for advice on COVID testing, as guidelines vary between states.

The Australian Journal of General Practice inappropriately retracts two ACCO publications on melanoma commissioned by the journal's Editor in Chief.

Details here   

Read our full rebuttal to the manuscript retractions here.


The ACCO item number ready reckoner:

ACCO 'ready reckoner' page 1     

ACCO 'ready reckoner' page 2

Assessing melanoma mortality risk - chart 

Vitamin B3 advice to our patients:-

Download the ACCO patient education sheet here.

The ACCO Mission

  • Workshops of quality  to further educate doctors & nurses
  • Examine and assess competence in managing skin cancer
  • Donate all proceeds over costs to medical research
  • All with the highest standards of impartiality

ACCO Certifications Pathway

Associate Fellow of ACCO
Fellow  of ACCO


In 2018 ACCO researchers published a renewed set off guidelines for appropriate management of superficial BCC and squamous cell carcinoma in situ. This was published in JAMA Dermatology. 


ACCO does not accept any funding from Governments, Universities or the Pharmaceutical industry. ACCO uses revenue from workshops to fund our ongoing research programs. Even our published drug trials were completed without drug company funding. ACCO regards true independence as critical. Even funding from Governments is tainted.. Governments have a vested interest in cheaper treatments or no treatments working as well as expensive methods. Without Government influence, ACCO research has often found that no treatment is superior to expensive treatments. 

© ACCO All rights retained - Founded in Victoria in 2006